Ursodiol-Methotrexate for Primary Biliary Cirrhosis
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The major thrust is to determine whether treatment of patients with Primary Biliary Cirrhosis
(PBC) with Ursodiol (Ursodeoxycholic Acid-UDCA) plus methotrexate (MTX) is more effective
than treatment with UDCA alone.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)